Michael J Fox wins apology from magazine over “disturbing” claims about his Parkinson’s

Perspectives

Author: Geoffrey ChangPublished: 4 May 2016

Prep: Cook: Serves:

Actor with Parkinson’s disease hits out at inaccurate article – magazine apologises calling Fox an “optimistic beacon of unflagging hope and inspiration”

Actor and leading Parkinson’s advocate Michael J Fox denounced the “disturbing” claims made about his health by US tabloid magazine, Globe, as “total B.S.”

The magazine wrote in its April edition that Fox had “refused to have life-saving surgery” and accepted “he has no hope of halting the terrifying ravage of crippling Parkinson’s disease”.

“With the tremors increasing, his bones buckling and facing possible dementia and Alzheimer’s… [Fox] realises his future is bleak,” the Globe report continued.

The 54-year-old took to Twitter to post a screenshot of the ‘clarification’ statement on Globe’s website, which included a retraction and apology, admitting that “Mr Fox continues to live a fulfilling, successful life”.

Fox posted to his 1.48 million followers: “Recent story in the Globe re my health and state of mind went viral. Disturbing and total B.S. The Globe apologises.”

Recent story in the Globe re my health and state of mind went viral. Disturbing and total B.S. The Globe apologizes. pic.twitter.com/5ZDgUNrYKe

— Michael J. Fox (@realmikefox) April 29, 2016

Image courtesy of The Michael J Fox Foundation for Parkinson’s Research

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

How Michael J Fox inspired my fight against Parkinson’s

My inspirational meeting with Michael J Fox

21 motivational Michael J Fox quotes on living with Parkinson’s disease

Inspiring MJ Fox quotes to mark ‘Back to the Future’ anniversary

‘Back To The Future’ sneakers to raise millions for Parkinson’s research

Nike will donate money raised from new limited edition sneakers

Chemical used in dry cleaning may be associated with Parkinson’s disease

The chemical trichloroethylene (TCE) has been used across a number of industries: to decaffeinate coffee, degrease metal parts, remove stains and dry-clean clothing. It’s currently banned in the European Union and the US states New York and Minnesota, except for authorised industrial uses. Now, scientists led by Dr Ray Dorsey in the US have conducted new research claiming that TCE could be linked to an increased risk of Parkinson’s. Published in the ‘Journal of Parkinson’s Disease’, the study investigated case studies of seven people who were exposed to TCE prior to a Parkinson’s diagnosis – including basketball legend Brian Grant. The researchers “postulate that this ubiquitous chemical is contributing to the global rise of Parkinson’s and that TCE is one of its invisible and highly preventable causes”. They called for the cleaning of TCE-contaminated sites and for indoor air exposure to be diminished – as well as for further studies to be…

Could certain cancers be linked to Parkinson’s disease?

Previous research has suggested that people with Parkinson’s may generally be less likely to develop most cancers. However, a new international study has found a potential genetic link between certain types of cancer and the condition. The team analysed genetic data from genome-wide association studies – a research approach that aims to identify gene variations associated with disease risk – to recognise common genetic risk factors between cancer and Parkinson’s. The findings uncovered a genetic link between the condition and both prostate cancer and melanoma. Meanwhile, the sum of various gene variants (otherwise known as the polygenic risk score) that contribute to Parkinson’s was significantly associated with a higher risk of breast cancer. “Our results suggest the importance of shared genetic variants between Parkinson’s and some cancers,” the researchers concluded in the study, which was published in the medical journal ‘Movement Disorders’. They highlighted the need for further studies to…

Investigational Parkinson’s disease dementia therapy fails in clinical trial

Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Michael J Fox wins apology from magazine over “disturbing” claims about his Parkinson’s

Perspectives

Author: Geoffrey ChangPublished: 4 May 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

How Michael J Fox inspired my fight against Parkinson’s

Perspectives

21 motivational Michael J Fox quotes on living with Parkinson’s disease

Global update

‘Back To The Future’ sneakers to raise millions for Parkinson’s research

Chemical used in dry cleaning may be associated with Parkinson’s disease

Could certain cancers be linked to Parkinson’s disease?

Investigational Parkinson’s disease dementia therapy fails in clinical trial

{title}

Subscribe

Michael J Fox wins apology from magazine over “disturbing” claims about his Parkinson’s

Perspectives

Author: Geoffrey ChangPublished: 4 May 2016

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

How Michael J Fox inspired my fight against Parkinson’s

Perspectives

21 motivational Michael J Fox quotes on living with Parkinson’s disease

Global update

‘Back To The Future’ sneakers to raise millions for Parkinson’s research

Chemical used in dry cleaning may be associated with Parkinson’s disease

Could certain cancers be linked to Parkinson’s disease?

Investigational Parkinson’s disease dementia therapy fails in clinical trial

{title}

Subscribe

Sign in